|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: TESSCO TECHNOLOGIES INC, 10-K, EX-23.1, 2000-06-14 |
Next: ICN PHARMACEUTICALS INC, SC 13D/A, 2000-06-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED MARCH 26, 2000
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000927355
<NAME> TESSCO TECHNOLOGIES INCORPORATED
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> MAR-26-2000
<PERIOD-START> MAR-29-1999
<PERIOD-END> MAR-26-2000
<EXCHANGE-RATE> 1
<CASH> 818,100
<SECURITIES> 0
<RECEIVABLES> 28,916,700
<ALLOWANCES> (739,300)
<INVENTORY> 31,723,800
<CURRENT-ASSETS> 63,762,100
<PP&E> 25,842,600
<DEPRECIATION> (8,681,700)
<TOTAL-ASSETS> 84,214,200
<CURRENT-LIABILITIES> 35,530,000
<BONDS> 7,128,700
0
0
<COMMON> 47,700
<OTHER-SE> 41,034,500
<TOTAL-LIABILITY-AND-EQUITY> 84,214,200
<SALES> 196,830,300
<TOTAL-REVENUES> 196,830,300
<CGS> 142,523,000
<TOTAL-COSTS> 142,523,000
<OTHER-EXPENSES> 44,027,400
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 1,340,300
<INCOME-PRETAX> 8,939,600
<INCOME-TAX> 3,397,000
<INCOME-CONTINUING> 5,542,600
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 5,542,600
<EPS-BASIC> 1.24
<EPS-DILUTED> 1.20
</TABLE>
|
|